Beddow Capital Management Inc Pfizer Inc Transaction History

Beddow Capital Management Inc

$244 Million
Q3 2024

A detailed history of Beddow Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Beddow Capital Management Inc holds 170,560 shares of PFE stock, worth $4.36 Million. This represents 2.02% of its overall portfolio holdings.

Number of Shares

170,560

Previous 168,360 1.31%

Holding current value

$4.36 Million

Previous $4.71 Million 4.78%

% of portfolio

2.02%

Previous 2.06%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$27.7 - $31.39 $60,940 - $69,058	2,200 Added 1.31%	170,560 $4.94 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $365,638 - $428,460	14,475 Added 9.41%	168,360 $4.71 Million
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $730,719 - $839,099	28,224 Added 22.46%	153,885 $4.27 Million
Q4 2023 Jan 25, 2024	BUY	$26.13 - $33.94 $572,247 - $743,286	21,900 Added 21.11%	125,661 $3.62 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $390,246 - $456,159	12,161 Added 13.28%	103,761 $3.44 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $19,324 - $22,357	-535 Reduced 0.58%	91,600 $3.36 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $421,945 - $549,311	10,712 Added 13.16%	92,135 $3.76 Million
Q4 2022 Feb 02, 2023	BUY	$41.75 - $54.5 $125,250 - $163,500	3,000 Added 3.83%	81,423 $4.17 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $24,068 - $29,381	550 Added 0.71%	78,423 $3.43 Million
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $58,162 - $68,962	1,250 Added 1.63%	77,873 $4.08 Million
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $416,462 - $516,049	9,103 Added 13.48%	76,623 $3.97 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $262,382 - $388,937	-6,350 Reduced 8.6%	67,520 $3.99 Million
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $2.51 Million - $3.22 Million	-63,858 Reduced 46.37%	73,870 $3.18 Million
Q2 2021 Aug 05, 2021	BUY	$35.91 - $40.68 $41,942 - $47,514	1,168 Added 0.86%	137,728 $5.39 Million
Q1 2021 Apr 08, 2021	BUY	$33.49 - $37.77 $181,013 - $204,146	5,405 Added 4.12%	136,560 $4.95 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $251,694 - $320,051	7,520 Added 6.08%	131,155 $4.83 Million
Q3 2020 Nov 05, 2020	SELL	$31.75 - $37.25 $45,243 - $53,081	-1,425 Reduced 1.14%	123,635 $4.54 Million
Q2 2020 Aug 05, 2020	SELL	$30.12 - $36.54 $384,873 - $466,908	-12,778 Reduced 9.27%	125,060 $4.09 Million
Q1 2020 May 07, 2020	BUY	$27.03 - $38.62 $946 - $1,351	35 Added 0.03%	137,838 $4.5 Million
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $9,480 - $10,759	288 Added 0.21%	137,803 $5.4 Million
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $57,832 - $74,991	-1,780 Reduced 1.28%	137,515 $4.94 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $1.03 Million - $1.15 Million	-27,790 Reduced 16.63%	139,295 $6.03 Million
Q1 2019 May 13, 2019	SELL	$37.5 - $41.2 $908,625 - $998,276	-24,230 Reduced 12.66%	167,085 $7.1 Million
Q4 2018 Feb 06, 2019	SELL	$38.47 - $43.86 $1.3 Million - $1.48 Million	-33,755 Reduced 15.0%	191,315 $8.35 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $708,530 - $859,404	-20,555 Reduced 8.37%	225,070 $9.92 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $159,458 - $169,998	-4,835 Reduced 1.93%	245,625 $8.91 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $813,864 - $944,195	-25,505 Reduced 9.24%	250,460 $8.89 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $1.97 Million - $2.09 Million	59,300 Added 27.37%	275,965 $10 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $2.5 Million - $2.75 Million	-80,590 Reduced 27.11%	216,665 $7.34 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $576,910 - $635,531	-18,610 Reduced 5.89%	297,255 $10.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	315,865	315,865 $10.6 Million

Others Institutions Holding PFE

# of Institutions

3,259

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beddow Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Beddow Capital Management Inc with notifications on news.

Account

Beddow Capital Management Inc Pfizer Inc Transaction History